Feed GNFT
GN

Genfit S.A. GNFT NASDAQ · Healthcare · France

$7.82 -6.18% -$0.52

Summary

26 / 100 · Bulios Score

What speaks for it

  • It earns 12 EUR a year on every 100 EUR of invested capital.
  • It could repay all its net debt from 1.3 years of operating profit.

What to watch

  • Revenue fell by 13% a year over the last 3 years.
  • It reports a profit, yet spends more cash than it brings in.
  • It passes only 2 of the 9 points of the Piotroski financial health test.
  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

  • Analyst estimate

Revenue grew by 17% a year over 5 years. Over the last 3 years it fell by 13% a year.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Yes

It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

86% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

This revenue breakdown is on the way.

By region

This revenue breakdown is on the way.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy